India to Taiwan: Kit Export Trade Route

The India to Taiwan Kit corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $90 USD. The route is dominated by VINAYAK PHARMA CORP, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's kit manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $90 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with kit's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 29.2%, placing it at rank #10 among India's top kit export destinations globally.

On the import side, key buyers of Indian kit in Taiwan include TO THE-. TO THE- is the single largest importer with 1 shipments valued at $90 USD.

India's kit exports to Taiwan are driven primarily by a handful of large-scale manufacturers. VINAYAK PHARMA CORP with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Taiwan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VINAYAK PHARMA CORP — together account for 100% of total trade value on this route. The average shipment value of $90 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, TO THE- is the largest importer with 1 shipments worth $90 USD — representing 100% of all kit imports from India on this route.